DRRX
Price
$0.54
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
33.11M
OGI
Price
$1.35
Change
+$0.04 (+3.05%)
Updated
Jun 6 closing price
Capitalization
200.85M
Interact to see
Advertisement

DRRX vs OGI

Header iconDRRX vs OGI Comparison
Open Charts DRRX vs OGIBanner chart's image
DURECT
Price$0.54
Change-$0.00 (-0.00%)
Volume$36.04K
Capitalization33.11M
Organigram Global
Price$1.35
Change+$0.04 (+3.05%)
Volume$667.21K
Capitalization200.85M
DRRX vs OGI Comparison Chart
Loading...
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRRX vs. OGI commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRRX is a Hold and OGI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (DRRX: $0.54 vs. OGI: $1.35)
Brand notoriety: DRRX and OGI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DRRX: 28% vs. OGI: 129%
Market capitalization -- DRRX: $33.11M vs. OGI: $200.85M
DRRX [@Pharmaceuticals: Other] is valued at $33.11M. OGI’s [@Pharmaceuticals: Other] market capitalization is $200.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRRX’s FA Score shows that 0 FA rating(s) are green whileOGI’s FA Score has 0 green FA rating(s).

  • DRRX’s FA Score: 0 green, 5 red.
  • OGI’s FA Score: 0 green, 5 red.
According to our system of comparison, OGI is a better buy in the long-term than DRRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRRX’s TA Score shows that 5 TA indicator(s) are bullish while OGI’s TA Score has 2 bullish TA indicator(s).

  • DRRX’s TA Score: 5 bullish, 3 bearish.
  • OGI’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, DRRX is a better buy in the short-term than OGI.

Price Growth

DRRX (@Pharmaceuticals: Other) experienced а +1.83% price change this week, while OGI (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +78.59%. For the same industry, the average monthly price growth was +15.33%, and the average quarterly price growth was +66.92%.

Reported Earning Dates

DRRX is expected to report earnings on Mar 27, 2025.

OGI is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+78.59% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OGI($201M) has a higher market cap than DRRX($33.1M). OGI YTD gains are higher at: -16.149 vs. DRRX (-27.867). DRRX has higher annual earnings (EBITDA): -33.66M vs. OGI (-195.74M). OGI has more cash in the bank: 42.3M vs. DRRX (39M). OGI has less debt than DRRX: OGI (136K) vs DRRX (23.2M). OGI has higher revenues than DRRX: OGI (161M) vs DRRX (9.19M).
DRRXOGIDRRX / OGI
Capitalization33.1M201M16%
EBITDA-33.66M-195.74M17%
Gain YTD-27.867-16.149173%
P/E RatioN/AN/A-
Revenue9.19M161M6%
Total Cash39M42.3M92%
Total Debt23.2M136K17,059%
FUNDAMENTALS RATINGS
DRRX vs OGI: Fundamental Ratings
DRRX
OGI
OUTLOOK RATING
1..100
515
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9792
PRICE GROWTH RATING
1..100
9047
P/E GROWTH RATING
1..100
10043
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (50) in the null industry is in the same range as DRRX (54) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to DRRX’s over the last 12 months.

OGI's Profit vs Risk Rating (100) in the null industry is in the same range as DRRX (100) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to DRRX’s over the last 12 months.

OGI's SMR Rating (92) in the null industry is in the same range as DRRX (97) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to DRRX’s over the last 12 months.

OGI's Price Growth Rating (47) in the null industry is somewhat better than the same rating for DRRX (90) in the Pharmaceuticals Other industry. This means that OGI’s stock grew somewhat faster than DRRX’s over the last 12 months.

OGI's P/E Growth Rating (43) in the null industry is somewhat better than the same rating for DRRX (100) in the Pharmaceuticals Other industry. This means that OGI’s stock grew somewhat faster than DRRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DRRXOGI
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCNAX43.23N/A
N/A
Fidelity Advisor Consumer Discret A
GEQZX59.22N/A
N/A
GuideStone Funds Equity Index Investor
FVALX5.78N/A
N/A
Forester Value N
FEUIX27.64N/A
N/A
Fidelity Advisor Glbl Capital Apprec I
TFGRX43.58N/A
N/A
Touchstone Mid Cap Growth R6

DRRX and

Correlation & Price change

A.I.dvisor tells us that DRRX and UPC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DRRX and UPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRRX
1D Price
Change %
DRRX100%
+0.37%
UPC - DRRX
27%
Poorly correlated
+2.14%
SNDL - DRRX
24%
Poorly correlated
+2.33%
OGI - DRRX
22%
Poorly correlated
+3.05%
ACB - DRRX
22%
Poorly correlated
+5.73%
ZOMDF - DRRX
22%
Poorly correlated
-2.09%
More